According to the report, 7.5 million individuals were diagnosed with tuberculosis in 2022.

This is the highest total since WHO began global TB tracking in 1995.

The increase is attributable to improved access to and provision of health services.

Globally, a projected 10.6 million people contracted tuberculosis (TB) in 2022, up from 10.3 million in 2021.

Geographically, the majority of people who contracted tuberculosis in 2022 lived in the WHO Regions of Southeast Asia (46%), Africa (23%), and the Western Pacific (18%).

India, Indonesia, and the Philippines together contributed to more than 60% of global reductions in newly diagnosed tuberculosis in 2020 and 2021.

Despite a significant recovery in 2022, progress was insufficient to meet global TB targets set in 2018.

The net decrease in TB-related deaths from 2015 to 2022 was 19%, falling far short of the WHO End TB Strategy milestone of a 75% reduction by 2025.

The cumulative reduction in TB incidence rate from 2015 to 2022 was 8.7%, falling far short of the WHO End TB Strategy milestone of a 50% reduction by 2025.

Over 50% of TB patients and their households experienced catastrophic total expenses, significantly exceeding the WHO End TB Strategy target of zero.

Less than half of the cash earmarked for TB care delivery and research was mobilized.

Further efforts are needed to reach the targets set in 2018.